Claritas PharmaceuticalsCLAZF
13F holders, Q2 2025 (June 30)1holders
$0.00avg. 13F price*
At the end of Q2 2025, 1 institutions reported holding Claritas Pharmaceuticals Inc. (CLAZF) in their 13F filings. The largest holder was GFG Capital, LLC ($4).
- Company
- Claritas Pharmaceuticals Inc.
- CUSIP
- 180634206
- Latest filing quarter
- Q2 2025
Total Exit/New Position Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $4 |
| Exits | 0 | $0 |
Ownership 1 holders
| GFG Capital, LLC | 0.00% | New | 4,333 | $4 |
"% of holder's portfolio" is CLAZF's weight in each manager's 13F, not the share of Claritas Pharmaceuticals Inc. the manager owns.